Understand the source comparison
Peptides vs Traditional Nootropics: Mechanism Comparison
Dihexa (peptide) HGF receptor agonist. Increases synaptic density and dendritic spine formation in hippocampus Yes (passive diffusion, MW 496 Da) 45–90 minutes 15–25% improvement in spatial memory tasks (rodent models) Most direct synaptogenic effect of any sm
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dihexa (peptide)
- HGF receptor agonist. Increases synaptic density and dendritic spine formation in hippocampus
- Yes (passive diffusion, MW 496 Da)
- 45–90 minutes
- 15–25% improvement in spatial memory tasks (rodent models)
- Most direct synaptogenic effect of any small-molecule compound. Requires precise dosing due to narrow therapeutic window
- Cerebrolysin (peptide mix)
- Delivers BDNF, NGF, CNTF. Neuroprotection and neuroplasticity enhancement
- Yes (receptor-mediated transcytosis)
- 2–4 hours (systemic), 7–14 days (structural changes)
- 20–30% MMSE score improvement in dementia cohorts after 20-day cycles
- Clinical-grade evidence in human populations. Injectable administration limits accessibility
- P21 (CNTF analogue)
- JAK-STAT pathway activation. Upregulates neurogenesis in dentate gyrus
- Yes (intranasal delivery to olfactory bulb)
- 15–30 minutes
- 35% memory retention improvement in aged rodent models
- Intranasal route avoids first-pass metabolism. Limited human trial data compared to Cerebrolysin
- Racetams (piracetam, aniracetam)
- AMPA receptor modulation. Increases glutamate signaling
- Partial (depends on lipophilicity)
- 30–60 minutes
- 5–10% cognitive speed improvements in healthy adults
- Weak effect size compared to peptides. Safe but marginal benefit
- Caffeine + L-theanine
- Adenosine receptor antagonism + GABA modulation
- Yes (both compounds)
- 10–15% attention and reaction time improvement
- Reliable acute effect with no structural neural changes. Tolerance develops within 7–14 days